Uncategorized
Semaglutide 5mg – GLP-1 Weight Loss Peptide – Deus Medical
Semaglutide – 5mg/vial – Deus Medical
🧬 What Is Semaglutide?
Semaglutide is a GLP-1 receptor agonist originally developed for the treatment of type 2 diabetes and later found to be highly effective for weight management. It mimics the action of glucagon-like peptide-1, helping regulate insulin, suppress appetite, and promote fat loss.
Deus Medical’s Semaglutide 5mg/vial provides high-quality research-grade peptide for scientific studies exploring metabolic health, appetite regulation, and obesity-related mechanisms.
⚠️ For research use only. Not intended for human or veterinary consumption.
⚙️ How Semaglutide Works
Semaglutide binds to GLP-1 receptors in the pancreas and brain. This leads to:
- Increased insulin secretion
- Decreased glucagon production
- Slowed gastric emptying
- Appetite suppression via hypothalamic signaling
Its long half-life (approx. 7 days) allows weekly administration in experimental settings.
🔍 Research Applications & Benefits
🔥 Appetite suppression & caloric intake reduction
⚖️ Sustainable fat loss in metabolic studies
🩺 Improved insulin sensitivity & glycemic control
🧠 Potential cognitive benefits from neuroprotective GLP-1 action
💊 Investigated for use in PCOS, NAFLD, and cardiometabolic conditions
💉 Dosage & Administration (For Lab Use)
- Typical Research Dose: 0.25–1.5 mg once weekly, titrated
- Reconstitution: Use sterile bacteriostatic water
- Administration: Subcutaneous injection
- Storage: Refrigerate after mixing; stable for up to 30 days
⚠️ Safety & Handling
Semaglutide is well-tolerated in clinical research. Most common side effects in studies include nausea, fullness, and slowed digestion. Long-term studies focus on its safety in metabolic and cardiovascular systems.
- Not for human consumption
- Use in controlled lab environments only